Literature DB >> 23292253

[Penile carcinoma: diagnosis and therapy].

C Protzel1, O W Hakenberg.   

Abstract

Penile carcinoma is fortunately a relatively rare disease in central Europe because advanced tumor stages are incurable. However, this rarity results in disadvantages for those affected because data from large series as an evidence basis are rare, the formulation of guidelines is often correspondingly vague and research funding for therapy studies is limited. Penile carcinoma is an orphan disease. Despite these disadvantageous characteristics research on the molecular biological basis of penile carcinoma has made some progress in recent years. This article gives a current review of all relevant aspects of this disease.

Entities:  

Mesh:

Year:  2013        PMID: 23292253     DOI: 10.1007/s00120-012-3004-5

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  32 in total

1.  18F-FDG PET/CT for staging of penile cancer.

Authors:  Bernhard Scher; Michael Seitz; Martin Reiser; Edwin Hungerhuber; Klaus Hahn; Reinhold Tiling; Peter Herzog; Maximilian Reiser; Peter Schneede; Stefan Dresel
Journal:  J Nucl Med       Date:  2005-09       Impact factor: 10.057

2.  Risk factors for squamous cell carcinoma of the penis--population-based case-control study in Denmark.

Authors:  Birgitte Schütt Madsen; Adriaan J C van den Brule; Helle Lone Jensen; Jan Wohlfahrt; Morten Frisch
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-10       Impact factor: 4.254

3.  Proof of activity of anti-epidermal growth factor receptor-targeted therapy for relapsed squamous cell carcinoma of the penis.

Authors:  Andrea Necchi; Nicola Nicolai; Maurizio Colecchia; Mario Catanzaro; Tullio Torelli; Luigi Piva; Roberto Salvioni
Journal:  J Clin Oncol       Date:  2011-05-31       Impact factor: 44.544

4.  Cisplatin, methotrexate and bleomycin for the treatment of carcinoma of the penis: a Southwest Oncology Group study.

Authors:  G P Haas; B A Blumenstein; R G Gagliano; C A Russell; S E Rivkin; D J Culkin; M Wolf; E D Crawford
Journal:  J Urol       Date:  1999-06       Impact factor: 7.450

5.  Alterations in the tumor suppressor gene p16(INK4A) are associated with aggressive behavior of penile carcinomas.

Authors:  Micaela Poetsch; Martin Hemmerich; Christoph Kakies; Britta Kleist; Eduard Wolf; Frank vom Dorp; Oliver W Hakenberg; Chris Protzel
Journal:  Virchows Arch       Date:  2010-11-18       Impact factor: 4.064

6.  What surgical resection margins are required to achieve oncological control in men with primary penile cancer?

Authors:  Suks Minhas; Oliver Kayes; Paul Hegarty; Pardeep Kumar; Alex Freeman; David Ralph
Journal:  BJU Int       Date:  2005-11       Impact factor: 5.588

7.  Epidemiologic study on penile cancer in Brazil.

Authors:  Luciano A Favorito; Aguinaldo C Nardi; Mario Ronalsa; Stenio C Zequi; Francisco J B Sampaio; Sidney Glina
Journal:  Int Braz J Urol       Date:  2008 Sep-Oct       Impact factor: 1.541

8.  Fluorescence-guided laser therapy for penile carcinoma and precancerous lesions: long-term follow-up.

Authors:  Boris Schlenker; Christian Gratzke; Michael Seitz; Markus J Bader; Oliver Reich; Peter Schneede; Edwin Hungerhuber; Christian G Stief; Derya Tilki
Journal:  Urol Oncol       Date:  2009-11-27       Impact factor: 3.498

Review 9.  Lymphadenectomy in the surgical management of penile cancer.

Authors:  Chris Protzel; Antonio Alcaraz; Simon Horenblas; Giorgio Pizzocaro; Alexandre Zlotta; Oliver W Hakenberg
Journal:  Eur Urol       Date:  2009-02-23       Impact factor: 20.096

10.  Screening of microsatellite markers in penile cancer reveals differences between metastatic and nonmetastatic carcinomas.

Authors:  Micaela Poetsch; Ben-John Schuart; Günther Schwesinger; Britta Kleist; Chris Protzel
Journal:  Mod Pathol       Date:  2007-08-10       Impact factor: 7.842

View more
  3 in total

1.  [Neoadjuvant, adjuvant and palliative chemotherapy of penile cancer].

Authors:  C Protzel; A K Seitz; O W Hakenberg; M Retz
Journal:  Urologe A       Date:  2013-11       Impact factor: 0.639

Review 2.  [Penile cancer: diagnosis and staging].

Authors:  K-D Sievert; D-L Dräger; F-M Köhn; S Milerski; C Protzel; O W Hakenberg
Journal:  Urologe A       Date:  2018-04       Impact factor: 0.639

3.  Reproducibility of histopathologic tumor grading in penile cancer--results of a European project.

Authors:  Ch Kakies; A Lopez-Beltran; E Comperat; A Erbersdobler; R Grobholz; O W Hakenberg; A Hartmann; L-C Horn; A K Höhn; J Köllermann; G Kristiansen; R Montironi; M Scarpelli; Ch Protzel
Journal:  Virchows Arch       Date:  2014-02-18       Impact factor: 4.064

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.